Atezolizumab: A novel PD-L1 inhibitor in cancer therapy with a focus in bladder and non-small cell lung cancers.
Anuradha Krishnamurthy, Antonio Jimeno
págs. 217-238
Crisaborole: Phosphodiesterase inhibitor for treatment of atopic dermatitis.
David M. Paton
págs. 239-246
Olaratumab for the treatment of soft tissue sarcoma.
A. Deshpande, M. Cecchini, S. Ni Choileain, Adam R. Jones
págs. 247-256
European Association of Urology – 32nd Annual Congress (March 24-28, 2017 - London, UK).
Raj Sharman
págs. 257-264
New product intros (bezlotoxumab, rintatolimod, telotristat etiprate).
pág. 265
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: